Aclarubicin
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Aclarubicin (INN) or aclacinomycin A[1] is an anthracycline drug[2] that is used in the treatment of cancer. Soil bacteria Streptomyces galilaeus can produce aclarubicin.
References
References
- ↑ Template:PubChem
- ↑ Jensen PB, Jensen PS, Demant EJ; et al. (October 1991). “Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II”. Cancer Res. 51 (19): 5093–9. PMID 1655244.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH